Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 198,321 | 175,338 | 164,246 | 154,937 | 133,591 |
| Cost of Goods | 6,126 | 5,234 | 5,527 | 3,605 | 4,554 |
| Gross Profit | 192,195 | 170,104 | 158,719 | 151,332 | 129,037 |
| Operating Expenses | 368,484 | 307,699 | 239,286 | 205,728 | 187,805 |
| Operating Income | -176,163 | -137,361 | -80,040 | -53,791 | -58,214 |
| Interest Expense | 19,050 | 18,828 | 9,810 | 4,422 | 4,734 |
| Other Income | 6,423 | 9,741 | -12,017 | -150 | 5,366 |
| Pre-tax Income | -188,790 | -146,448 | -101,867 | -58,363 | -57,582 |
| Income Tax | -19,359 | -21 | 811 | 1,368 | -9,679 |
| Net Income Continuous | -169,431 | -146,427 | -102,678 | -59,731 | -47,903 |
| Net Income | $-169,431 | $-146,427 | $-102,678 | $-59,731 | $-47,903 |
| EPS Basic Total Ops | -3.56 | -3.46 | -2.54 | -1.54 | -1.29 |
| EPS Basic Continuous Ops | -3.56 | -3.46 | -2.54 | -1.54 | -1.29 |
| EPS Diluted Total Ops | -3.56 | -3.46 | -2.54 | -1.54 | -1.29 |
| EPS Diluted Continuous Ops | -3.56 | -3.46 | -2.54 | -1.54 | -1.25 |
| EPS Diluted Before Non-Recurring Items | -3.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-141,106 | $-82,338 | $-57,592 | $-33,993 | $-40,326 |